Observational Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Mar 27, 2025; 17(3): 95983
Published online Mar 27, 2025. doi: 10.4240/wjgs.v17.i3.95983
Table 4 Clinical characteristics and outcomes between the high-risk and low-risk cohorts of anastomotic leakage patients
Variables
High-risk cohort of AL (n = 408)
Low-risk cohort of AL (n = 97)
P value
Tumor size, median (range) mm0.212
    > 35208 (60.0)42 (43.3)
    ≤ 35200 (40.0)55 (56.7)
Differentiation status0.625
    Poor61 (15.0)12 (12.4)
    Well-moderate347 (85.0)85 (87.6)
pT stage0.014
    0-2160 (39.2)52 (53.6)
    3248 (60.8)45 (46.4)
pN stage0.267
    N+149 (36.5)29 (29.9)
    N0259 (63.5)68 (70.1)
M stage0.140
    M19 (2.2)0 (0)
    M0399 (97.8)97 (100)
pTNM stage0.047
    I-II252 (61.8)71 (73.2)
    III-IV156 (38.2)26 (26.8)
Tumor height from anal verge, median (range) cm0.530
    ≤ 4.0309 (75.7)77 (79.4)
    > 4.099 (24.3)20 (20.6)
Operative time, median (range) min164 (130-195)175 (139-218)0.006
Blood loss, median (range) mL50 (20-50)50 (20-100)0.003
Conversion to open surgery0 (0)0 (0)1
Postoperative complication67 (16.4)7 (7.2)0.021
    CD grade I-II46 (11.3)5 (5.2)0.072
    CD grade ≥ III21 (5.1)2 (2.1)0.299
AL42 (10.3)2 (2.1)0.010
    Grade A-B 35 (8.6)2 (2.1)0.027
    Grade C 7 (1.7)0 (0)0.415
Mortality3 (0.7)0 (0)0.397
Reoperation10 (2.5)1 (1.0)0.635
Postoperative hospital stay (day)9 (4-50)10 (4-47)0.081
Anastomosis recurrence7 (1.7)1 (1.0)0.974